Issued Patents All Time
Showing 25 most recent of 108 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12312331 | Imidazolyl pyrimidinylamine compounds as CDK2 inhibitors | Qinda Ye, Jingwei Li, Ken Mukai, Brandon Smith, Wenqing Yao +4 more | 2025-05-27 |
| 12247026 | Heterocyclic compounds as immunomodulators | Jingwei Li, Wenqing Yao | 2025-03-11 |
| 12247038 | Pyrido[3,2-d]pyrimidine compounds as immunomodulators | Jingwei Li, Wenqing Yao | 2025-03-11 |
| 12187743 | Heterocyclic compounds as immunomodulators | Kaijiong Xiao, Wenqing Yao | 2025-01-07 |
| 12187725 | Tricyclic urea compounds as JAK2 V617F inhibitors | Yanran Ai, Yu Sheng Bai, Joseph Barbosa, Hao Feng, Leah C. Konkol +5 more | 2025-01-07 |
| 12129267 | Heteroaryl amide compounds as sting activators | Neil Lajkiewicz, Wenqing Yao | 2024-10-29 |
| 12060433 | CD73 inhibitor and A2A/A2B adenosine receptor inhibitor combination therapy | Horacio G. Nastri, Shaun M. Stewart, Juan Carlos Almagro, Jing Zhou, Rebecca A. Buonpane +9 more | 2024-08-13 |
| 12030889 | Imidazopyridazine and imidazopyridine compounds and uses thereof | Jun Pan, Jeremy Roach, Song Mei, Chunhong He, Wenqing Yao | 2024-07-09 |
| 11999740 | Fused pyrazine derivatives as A2A / A2B inhibitors | Xiaozhao Wang, Peter Carlsen, Pei Gan, Gia Hoang, Yong Li +3 more | 2024-06-04 |
| 11981671 | Bicyclic pyrazolyl amines as CDK2 inhibitors | Joshua Hummel, Jingwei Li, Ding-Quan Qian | 2024-05-14 |
| 11958861 | Spirocyclic lactams as JAK2 V617F inhibitors | Stacey Shepard, Charles Cole, Nikoo Falahatpisheh, Kai Liu, Lixin Shao +3 more | 2024-04-16 |
| 11919904 | Sulfonylamide compounds as CDK2 inhibitors | Alexander Sokolsky, Sarah Winterton, Wenqing Yao, Min Ye, Yingnan Chen +2 more | 2024-03-05 |
| 11919908 | Substituted pyrrolo[2,3-d]pyrimidine compounds as JAK2 V617F inhibitors | Andrew W. Buesking, Onur Atasoylu, Cheng-Tsung Lai, Padmaja Polam, Wenqing Yao | 2024-03-05 |
| 11912722 | Tricyclic heteroaryl compounds as sting activators | Yingda Ye, Wenqing Yao | 2024-02-27 |
| 11873309 | Heterocyclic compounds as immunomodulators | Kaijiong Xiao, Fenglei Zhang, Wenqing Yao | 2024-01-16 |
| 11873304 | Fused pyrimidine derivatives as A2A/A2B inhibitors | Xiaozhao Wang, Heeoon Han, Matthew S. McCammant, Wenqing Yao, Zhiyong Yu +1 more | 2024-01-16 |
| 11866435 | Heterocyclic compounds as immunomodulators | Neil Lajkiewicz, Wenqing Yao | 2024-01-09 |
| 11866432 | Dihydropyrido[2,3-d]pyrimidinone compounds as CDK2 inhibitors | Alexander Sokolsky, Wenqing Yao | 2024-01-09 |
| 11851426 | Bicyclic amines as CDK2 inhibitors | Yingda Ye, Zhenwu Li, Ding-Quan Qian, Sarah Winterton, Wenqing Yao | 2023-12-26 |
| 11840534 | Substituted tricyclic compounds as FGFR inhibitors | Colin Zhang, Chunhong He, Liang Lu, Wenqing Yao | 2023-12-12 |
| 11840546 | Imidazopyridazine compounds and uses thereof | Jun Pan, Yu Sheng Bai, Wenqing Yao | 2023-12-12 |
| 11787793 | Heterocyclic compounds as immunomodulators | Jingwei Li, Wenqing Yao | 2023-10-17 |
| 11780840 | Tricyclic urea compounds as JAK2 V617F inhibitors | Yanran Ai, Onur Atasoylu, Yu Sheng Bai, Joseph Barbosa, David M. Burns +11 more | 2023-10-10 |
| 11767323 | Tricyclic pyridone compounds as JAK2 V617F inhibitors | Kai Liu, Onur Atasoylu, Yu Sheng Bai, Andrew W. Buesking, Leah C. Konkol +4 more | 2023-09-26 |
| 11753413 | Substituted pyrrolo[2,1-f][1,2,4]triazine compounds as JAK2 V617F inhibitors | Zhiyong Yu, Wenqing Yao | 2023-09-12 |